Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
The Australasian Journal of Dermatology|May 20, 2003
Clinical study of primary cutaneous B-cell lymphoma using both the European Organization for Research and Treatment of Cancer and World Health Organization classificationsLee Mei Yap, Robert Blum, Peter Foley, et al.
Clinical and Experimental Dermatology|February 12, 2022
Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerizationChristopher Baker, Amelia James, Madeleine Supranowicz, et al.
European Journal of Radiology|March 3, 2009
The role of interventional radiology in obstetric and gynaecology practiceArul Ganeshan, Sarfraz Ahmed Nazir, Lye Quen Hon, et al.
The Australasian Journal of Dermatology|August 8, 2009
Refractory subacute cutaneous lupus erythematosus successfully treated with rituximabViolet Kieu, Timothy O'Brien, Lee-Mei Yap, et al.
Multiple Sclerosis and Related Disorders|May 16, 2022
The influence of disease-modifying therapy on hidden disability burden in people with newly diagnosed relapsing-remitting multiple sclerosisStella A Glasmacher, Patrick Ka Kearns, Zackary Hassan, et al.
Multiple Sclerosis and Related Disorders|June 7, 2022
Efficacy of Fluoxetine, Riluzole and Amiloride in treating neuropathic pain associated with secondary progressive multiple sclerosis. Pre-specified analysis of the MS-SMART double-blind randomised placebo-controlled trialPeter Foley, Richard A Parker, Floriana de Angelis, et al.
The New England Journal of Medicine|September 13, 2018
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in PsoriasisKim Papp, Kenneth Gordon, Diamant Thaçi, et al.
American Journal of Clinical Dermatology|November 13, 2018
Improvement in Patient-Reported Outcomes (Dermatology Life Quality Index and the Psoriasis Symptoms and Signs Diary) with Guselkumab in Moderate-to-Severe Plaque Psoriasis: Results from the Phase III VOYAGE 1 and VOYAGE 2 StudiesApril W Armstrong, Kristian Reich, Peter Foley, et al.
Acta Dermato-Venereologica|February 3, 2016
Effects of Apremilast on Pruritus and Skin Discomfort/Pain Correlate With Improvements in Quality of Life in Patients With Moderate to Severe Plaque PsoriasisJeffrey M Sobell, Peter Foley, Darryl Toth, et al.
The Journal of Dermatological Treatment|May 11, 2016
Adherence to topical therapies in actinic keratosis: A literature reviewPeter Foley, Eggert Stockfleth, Ketty Peris, et al.
Pageof 17